Four-Month Tuberculosis Treatment Noninferior To Six-Month Standard Of Care Therapy, Study Finds

Infectious Disease Advisor (6/18, Gupta) reported, “A 4-month rifapentine-moxifloxacin-based regimen was found to be noninferior to the standard 6-month regimen for drug-susceptible pulmonary tuberculosis (TB), according to” researchers who evaluated data...